Analysis of differentially expressed genes in hypertension and hypertensive cerebral hemorrhage via RNA-sequencing

Hongwu Qi,Min Qiao,Yansong Liu,Weijun Zeng,Lizhao Zhang,Hongjun Guo

DOI: https://doi.org/10.1080/26895293.2024.2304349

IF: 1.044

2024-01-19

All Life

Abstract:Hypertension (HT) is a major cause of intracerebral hemorrhage (ICH), and hypertensive cerebral hemorrhage (HCH) has a serious impact on life quality of patients and gives society a heavy burden. This study investigated the key genes involved in HT and HCH. Three patients with HT, three with HCH, and three healthy individuals were recruited in the present study. Shared and specific differentially expressed genes (DEGs) in HT and HCH were identified using RNA sequencing and bioinformatics analysis. Functional annotation and protein–protein interaction (PPI) network construction of HT- and HCH-specific DEGs were conducted. Estimation of cell infiltration, drug prediction, and real-time qPCR (RT-qPCR) validation were performed. Compared with the controls, 502 and 1649 DEGs were identified in the HT and HCH groups, respectively. Among them, 378 DEGs were HT-specific and 633 DEGs were HCH-specific, and a total of 1771 DEGs were identified between HT and HCH. In addition, there were fewer immune cell types that differed significantly among the three groups. The RT-qPCR validation results in human subjects and cell models were generally consistent with the sequencing results. Our study may make a contribution for the understanding of the specific mechanisms of HT and HCH. Highlights

multidisciplinary sciences

What problem does this paper attempt to address?

The paper aims to investigate the mechanisms of differentially expressed genes (DEGs) in hypertension (HT) and hypertensive cerebral hemorrhage (HCH). Specifically:

1. **Research Background**: Hypertension is a major cause of cerebral hemorrhage, and hypertensive cerebral hemorrhage severely impacts patients' quality of life and imposes a heavy burden on society.

2. **Study Subjects**: The study recruited 3 hypertensive patients, 3 hypertensive cerebral hemorrhage patients, and 3 healthy control individuals.

3. **Main Findings**:
- Compared to the control group, 502 differentially expressed genes (DEGs) were identified in the hypertension group, with 282 upregulated and 220 downregulated.
- In the hypertensive cerebral hemorrhage group, 1649 differentially expressed genes were identified, with 1034 upregulated and 615 downregulated.
- A total of 1771 differentially expressed genes were identified between hypertension and hypertensive cerebral hemorrhage, with 1067 upregulated and 704 downregulated.
- 378 hypertension-specific differentially expressed genes and 633 hypertensive cerebral hemorrhage-specific differentially expressed genes were further analyzed.

4. **Functional Annotation and Protein-Protein Interaction Network**:
- Functional enrichment analysis of hypertension-specific differentially expressed genes showed significant enrichment in defense response, extracellular region, and other functions.
- Functional enrichment analysis of hypertensive cerebral hemorrhage-specific differentially expressed genes showed significant enrichment in viral transcription, translation termination, and other functions.
- Protein-protein interaction networks for hypertension and hypertensive cerebral hemorrhage-specific differentially expressed genes were constructed, identifying several key node genes.

5. **Immune Microenvironment Analysis and Drug Prediction**: The study also analyzed immune cell infiltration among different groups and predicted some potential therapeutic drugs, such as doxycycline, fasudil, and thioguanine.

6. **Validation Experiments**: The results of some differentially expressed genes were validated in human samples and cell models using real-time quantitative PCR (RT-qPCR).

In summary, this study reveals the molecular mechanisms of hypertension and its related cerebral hemorrhage through comprehensive analysis of differentially expressed genes, providing new insights into the specific mechanisms of these two diseases and potentially offering new directions for the development of therapeutic strategies.